Guayusa extract is a caffeinated tea leaf unique blend of antioxidants and caffeine. It is marketed as an ingredient that can help support energy and performance with potential health-related benefits. It has also been indicated as being as safe as any other existing teas (i.e., green tea). However, no studies have previous studied the dose-response effects of guayusa extract for supporting cognitive function, mood, metabolism, nor its effects on resting heart rate, blood pressure, and electrocardiogram characteristics.
Guayusa extract is a caffeinated Amazonian 'super-leaf' belonging to the holly species that contains a unique blend of polyphenol antioxidants and caffeine (\~20% caffeine, 30% chlorogenic acids, 5% catechins). It is also remarkably low in tannins which are responsible for the bitter taste found in most teas - giving it a sweet flavor profile. As such, it is marketed as an ingredient that can help support energy and performance (e.g., via caffeine content) with potential health-related benefits due to its antioxidant properties. Indeed, ingredients such as these are often consumed by individuals prior to exercise in order to help improve neurocognitive performance, mood, or otherwise to support health-related goals such as metabolism. Whereas several studies have suggested that caffeine and chlorogenic acid consumption may improve performance, mood, and concentration, and some evidence in animals have linked catechin consumption to improved health outcomes, no studies have previous studied whether guayusa extract supplementation helps to support these, nor has the dose-effectiveness been tested, in humans. In this study, the effects of acute dietary supplementation with two different doses of botanical organic guayusa extract on neurocognitive/motor-cognitive performance, mood, focus, and jitteriness, resting metabolism, and resting heart rate, blood pressure, and electrocardiogram characteristics will be examined.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
32
Participants will consume two vegan capsules with one capsule containing 600 mg AmaTea® and 1 containing 600 mg dextrose.
Participants will consume two vegan capsules with each capsule containing 600 mg AmaTea® (1200 mg total).
Participants will consume two vegan capsules with each capsule containing 600 mg dextrose (1200 mg total).
Integrative Laboratory of Applied Physiology and Lifestyle Medicine
Iowa City, Iowa, United States
Mood
Calculated as Total Mood Disturbance (arbitrary units) using the Profile of Mood States Short Form Questionnaire.
Time frame: 90-minutes Post-supplementation
Psychomotor Speed
How well participant perceived, attends, responds to visual-perceptive information, and performs motor speed and fine motor coordination. Calculated as the sum of finger taps in finger tapping test and correct responses in the symbol digit coding test.
Time frame: 60-minutes Post-supplementation
Executive Function
How well participant recognized rules, categories, and manages or navigates rapid decisions making. Calculated as the differences between Shifting Attention Test Correct Responses and Errors.
Time frame: 60-minutes Post-supplementation
Jitteriness
Participants will describe how jittery they feel after supplemention using a 0-100 mm visual analog scale.
Time frame: 90-minutes Post-supplementation
Focus
Participants will describe how focused they feel after supplemention using a 0-100 mm visual analog scale.
Time frame: 90-minutes Post-supplementation
Energy
Participants will describe how energetic they feel after supplemention using a 0-100 mm visual analog scale.
Time frame: 90-minutes Post-supplementation
Resting Metabolic Rate
Resting metabolic rate (kcal/min) will be quantified from resting, fasted analyses of pulmonary gas exchange.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 50 minutes post-supplementation
Resting Fat Oxidation
Resting fat oxidation (g/min) will be quantified from resting, fasted analyses of pulmonary gas exchange.
Time frame: 50 minutes post-supplementation
Resting Heart Rate
Heart rate (bpm) will be quantified from a standard 12-lead ECG
Time frame: -10 minutes before supplementation, 40 minutes post-supplementation
Resting Blood Pressure
Systolic, diastolic, and pulse pressures (mmHg) will be quantified from brachial artery via automated sphygmomanometer.
Time frame: -10 minutes before supplementation, 40 minutes post-supplementation
QTc Interval
QTc Interval (ms) will be quantified from a standard 12-lead ECG
Time frame: -10 minutes before supplementation, 40 minutes post-supplementation
Motor-Cognitive Reaction Time
Motor-cognitive reaction times (ms) will be quantified from motor cognitive (reactionary hop) tests
Time frame: 100-minutes Post-supplementation
Sustained Attention
How well a subject can direct and focus cognitive activity on specific stimuli. Derived from performance on the 4-part continuous performance task test.
Time frame: 60-minutes Post-supplementation
Working Memory
How well a subject can perceive and attend to symbols using short-term memory processes.
Time frame: 60-minutes Post-supplementation
Cognitive Flexibility
How well subject is able to adapt to rapidly changing and increasingly complex set of directions and/or to manipulate the information. Assessed from the Shifting Attention Task and Stoop Test as the Shifting Attention Task Correct Responses - Shifting Attention Task Incorrect Responses and Stroop Commission Errors.
Time frame: 60-minutes Post-supplementation